What one share of Fulgent Genetics holds
We are a technology-based company with a well-established laboratory services business and a therapeutic development business. Our laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians.
Fulgent Genetics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $10.74 |
|---|---|
| Profit | −$2.80 |
| Capex (buildings and equipment) | $0.67 |
| Free cash flow | −$3.44 |
| Cash and investments | $0.96 |
| Debt | $0.07 |
| Book value | $36.40 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | $0.81 | −$0.70 | $0.18 | −$0.26 | — | $0.43 |
| 2016 | $1.33 | −$1.00 | $0.28 | $0.04 | — | $3.08 |
| 2017 | $1.06 | −$0.14 | $0.16 | −$0.09 | — | $3.04 |
| 2018 | $1.19 | −$0.31 | $0.13 | −$0.17 | — | $2.81 |
| 2019 | $1.74 | −$0.02 | $0.06 | $0.23 | — | $3.85 |
| 2020 | $17.53 | $8.91 | $1.46 | $4.39 | — | $20.21 |
| 2021 | $32.04 | $16.38 | $0.77 | $16.62 | — | $38.42 |
| 2022 | $19.99 | $4.63 | $0.61 | $7.58 | — | $43.03 |
| 2023 | $9.71 | −$5.63 | $0.75 | $0.16 | — | $38.31 |
| 2024 | $9.38 | −$1.41 | $1.33 | −$0.64 | — | $36.74 |
| 2025 | $10.48 | −$1.97 | $0.73 | −$4.04 | — | $35.78 |
Common questions about Fulgent Genetics
How much does one share of Fulgent Genetics earn?
Over the last 12 months, Fulgent Genetics lost $2.80 for each share on $10.74 of sales.
Does Fulgent Genetics pay a dividend?
Fulgent Genetics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Fulgent Genetics’s book value per share?
Fulgent Genetics’s book value is $36.40 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Fulgent Genetics have?
Each share of Fulgent Genetics has $0.96 of cash and investments and $0.07 of debt, as of June 30, 2026.
What is Fulgent Genetics’s free cash flow per share?
−$3.44 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Fulgent Genetics bought back shares?
Fulgent Genetics’s share count rose about 160% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.